The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

By Mrinalika Roy and Michael Erman Feb 3(Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug from its recent $10 billion Metsera purchase that raises questions about its ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

Pfizer released trial data on a new obesity drug, raising concerns about tolerability. Despite a stock drop, the company aims ...

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...

Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney failure ...

Aug 22 (Reuters) - This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

Most people have an aversion to injecting drugs, especially intravenously; it's referred to as "the needle barrier." For much of the 20th century, this aversion was a powerful deterrent to the use of ...